Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
avapritinib
blueprint medicines
boston
2
×
boston blog main
2
×
cancer
2
×
life sciences
national blog main
andrew berens
biotech
boston top stories
cancer drugs
capmatinib
clinical trials
deciphera pharmaceuticals
eli lilly
europe blog main
europe top stories
gastrointestinal stromal tumor
gastrointestinal stromal tumors
genentech
gist
gleevec
imatinib
indiana blog main
indiana top stories
life science
medullary thyroid cancer
national top stories
non-small cell lung cancer
novartis
pralsetinib
regorafenib
ripretinib
roche
san francisco blog main
san francisco top stories
selpercatinib
steve hoerter
stivarga
sunitinib
What
approval
blueprint
2
×
cancer
drug
2
×
fda
address
announced
approves
carries
certain
chasing
deadly
deciphera
designed
filing
forms
genetic
gi
latest
medicine
medicines
morning
pass
pharamceuticals
plans
ret
seek
signature
signatures
targeted
targeting
therapy
treats
tumor
type
Language
unset
Current search:
cancer
×
drug
×
blueprint
×
boston
×
" boston blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug